Kirin Holdings is a major Japanese beverage and pharmaceutical group with operations spanning beer, spirits, non-alcoholic beverages, and pharmaceuticals. The company's Kirin Ichiban and Kirin Lager brands are among Japan's most established beer labels. Kirin has built a significant presence in Australia through its Lion subsidiary and holds a stake in a leading pharmaceutical company, giving it exposure to healthcare alongside its core beverage business.

For international investors, Kirin Holdings offers a distinctive combination of alcoholic beverages, non-alcoholic beverages, and pharmaceutical operations. The company's beer brands hold strong positions in Japan and Australia, while its pharmaceutical subsidiary, Kyowa Kirin, operates as an independently listed biopharmaceutical company with a global presence. This diversification across consumer beverages and healthcare provides a less cyclical earnings profile than a pure beverage company.